Abstract
Background
Recent studies suggest that platelet activation plays an important role in the pathophysiology of inflammatory bowel disease. In this study, we evaluated the effects of leukocytapheresis (LCAP) on platelet functions in patients with ulcerative colitis (UC).
Methods
Thirteen patients with active UC (five women and eight men) were treated with LCAP therapy. Platelet-rich plasma (PRP) was prepared, and platelet aggregation in response to agonist solution (epinephrine, collagen, and ADP) was measured with a platelet aggregometer. Platelet-derived microparticle (PDMP) plasma levels were determined by enzyme-linked immunosorbent assay.
Results
Nine patients responded to LCAP therapy, but no clinical responses were observed in four patients. The aggregation response to 0.1 µg/ml epinephrine was enhanced in all patients. In all responders, enhanced epinephrine aggregation was normalized after the LCAP session. However, in the four nonresponders, enhanced epinephrine aggregation was maintained after the LCAP session. In responders, the mean maximum aggregation induced by 0.1 µg/ml epinephrine was 76.8 ± 5.0% before and 15.4 ± 3.8% after LCAP, respectively (P < 0.05). Increased aggregation responses to both 0.2 µg/ml collagen and 1.0 µM ADP were observed, and LCAP also normalized these enhanced responses. LCAP significantly reduced circulating PDMP levels (56.8 ± 28.3 U/ml before and 46.3 ± 30.4 U/ml after LCAP, P < 0.05).
Conclusions
LCAP reduced enhanced platelet aggregation responses in active UC patients. Because platelets play an important role in inflammatory and immune responses, therapeutic effects of LCAP may be partially mediated by reduction of increased platelet aggregation activities.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
S Danese C de la Motte C Fiocchi (2004) ArticleTitlePlatelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications Am J Gastroenterol 99 938–45 Occurrence Handle15128364 Occurrence Handle10.1111/j.1572-0241.2004.04129.x
AS Weyrich GA Zimmerman (2004) ArticleTitlePlatelets: signaling cells in the immune continuum Trends Immunol 25 489–95 Occurrence Handle15324742 Occurrence Handle1:CAS:528:DC%2BD2cXmvFWmu7s%3D Occurrence Handle10.1016/j.it.2004.07.003
I Talstad K Rootwelt E Gjone (1973) ArticleTitleThrombocytosis in ulcerative colitis and Crohn's disease Scand J Gastroenterol 8 135–8 Occurrence Handle4697073 Occurrence Handle1:STN:280:DyaE3s7lsFOmuw%3D%3D
JW van Wersch P Houben J Rijken (1990) ArticleTitlePlatelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease J Clin Chem Clin Biochem 28 513–7 Occurrence Handle2258713 Occurrence Handle1:STN:280:DyaK3M%2FnvFOqtQ%3D%3D
AN Kapsoritakis MI Koukourakis A Sfiridaki SP Potamianos MG Kosmadaki IE Koutroubakis et al. (2001) ArticleTitleMean platelet volume: a useful marker of inflammatory bowel disease activity Am J Gastroenterol 96 776–81 Occurrence Handle11280550 Occurrence Handle1:STN:280:DC%2BD3M7ovFOrsA%3D%3D Occurrence Handle10.1111/j.1572-0241.2001.03621.x
R Quera F Shanahan (2004) ArticleTitleThromboembolism—an important manifestation of inflammatory bowel disease Am J Gastroenterol 99 1971–3 Occurrence Handle15447758 Occurrence Handle10.1111/j.1572-0241.2004.40923.x
W Miehsler W Reinisch E Valic W Osterode W Tillinger T Feichtenschlager et al. (2004) ArticleTitleIs inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53 542–8 Occurrence Handle15016749 Occurrence Handle1:STN:280:DC%2BD2c7lvFWhsw%3D%3D Occurrence Handle10.1136/gut.2003.025411
CE Collins MR Cahill AC Newland DS Rampton (1994) ArticleTitlePlatelets circulate in an activated state in inflammatory bowel disease Gastroenterology 106 840–5 Occurrence Handle8143990 Occurrence Handle1:STN:280:DyaK2c7pt12mtQ%3D%3D
AA Vrij J Rijken JW Van Wersch RW Stockbrugger (2000) ArticleTitlePlatelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis Eur J Clin Invest 30 188–94 Occurrence Handle10691994 Occurrence Handle1:CAS:528:DC%2BD3cXitlSjs70%3D Occurrence Handle10.1046/j.1365-2362.2000.00616.x
S Danese C de la Motte A Sturm JD Vogel GA West SA Strong et al. (2003) ArticleTitlePlatelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients Gastroenterology 124 1249–64 Occurrence Handle12730866 Occurrence Handle1:CAS:528:DC%2BD3sXktVSktrs%3D Occurrence Handle10.1016/S0016-5085(03)00289-0
S Danese JA Katz S Saibeni A Papa A Gasbarrini M Vecchi et al. (2003) ArticleTitleActivated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients Gut 52 1435–41 Occurrence Handle12970136 Occurrence Handle1:CAS:528:DC%2BD3sXotl2lu7c%3D Occurrence Handle10.1136/gut.52.10.1435
A Andoh T Yoshida Y Yagi S Bamba K Hata T Tsujikawa K Kitoh M Sasaki Y Fujiyama (2006) ArticleTitleIncreased aggregation response of platelets in patients with inflammatory bowel disease J Gastroenterol 41 47–54 Occurrence Handle16501857 Occurrence Handle1:CAS:528:DC%2BD28XhvVWjsrs%3D Occurrence Handle10.1007/s00535-005-1721-x
A Andoh T Tsujikawa K Hata Y Araki K Kitoh M Sasaki et al. (2005) ArticleTitleElevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease Am J Gastroenterol 100 2042–8 Occurrence Handle16128950 Occurrence Handle1:CAS:528:DC%2BD2MXhtFWmsLzN Occurrence Handle10.1111/j.1572-0241.2005.50381.x
K Yamaji K Yang H Tsuda H Hashimoto (2002) ArticleTitleFluctuations in sthe peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers Ther Apher 6 402–12 Occurrence Handle12460402 Occurrence Handle10.1046/j.1526-0968.2002.00459.x
T Hidaka K Suzuki Y Matsuki M Takamizawa-Matsumoto M Okada T Ishizuka et al. (1999) ArticleTitleChanges in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis Ther Apher 3 178–85 Occurrence Handle10341394 Occurrence Handle1:STN:280:DyaK1M3nt12nsg%3D%3D Occurrence Handle10.1046/j.1526-0968.1999.00136.x
Y Ueki S Yamasaki Y Kanamoto T Kawazu M Yano K Matsumoto et al. (2000) ArticleTitleEvaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis Rheumatology (Oxford) 39 165–71 Occurrence Handle1:STN:280:DC%2BD3c7ptVSnsA%3D%3D Occurrence Handle10.1093/rheumatology/39.2.165
T Hidaka K Suzuki M Kawakami M Okada K Kataharada T Shinohara et al. (2001) ArticleTitleDynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis J Clin Apher 16 74–81 Occurrence Handle11746532 Occurrence Handle1:STN:280:DC%2BD3MnpsFGjuw%3D%3D Occurrence Handle10.1002/jca.1016
K Sawada K Ohnishi S Fukui K Yamada M Yamamura K Amano et al. (1995) ArticleTitleLeukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease J Gastroenterol 30 322–9 Occurrence Handle7647899 Occurrence Handle1:STN:280:DyaK2MznsFyqtQ%3D%3D Occurrence Handle10.1007/BF02347507
K Sawada K Ohnishi T Kosaka S Chikano Y Yokota A Egashira et al. (1997) ArticleTitleLeukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis Ther Apher 1 207–11 Occurrence Handle10225739 Occurrence Handle1:STN:280:DyaK1M3ktValuw%3D%3D
K Nagase K Sawada K Ohnishi A Egashira K Ohkusu T Shimoyama (1998) ArticleTitleComplications of leukocytapheresis Ther Apher 2 120–4 Occurrence Handle10225712 Occurrence Handle1:STN:280:DyaK1M3ktVansA%3D%3D
T Hibi T Yajima (1997) ArticleTitleA novel therapy for corticosteroid-dependent or corticosteroid-resistant patients with ulcerative colitis Intern Med 36 317–8 Occurrence Handle9213164 Occurrence Handle1:STN:280:DyaK2szls1Ohug%3D%3D
K Sawada T Muto T Shimoyama M Satomi T Sawada H Nagawa et al. (2003) ArticleTitleMulticenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column Curr Pharm Des 9 307–21 Occurrence Handle12570823 Occurrence Handle1:CAS:528:DC%2BD3sXksl2nug%3D%3D Occurrence Handle10.2174/1381612033391928
A Andoh A Ogawa K Kitamura O Inatomi S Fujino T Tsujikawa et al. (2004) ArticleTitleSuppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis J Gastroenterol 39 1150–7 Occurrence Handle15622478 Occurrence Handle1:CAS:528:DC%2BD2MXhtFSqsQ%3D%3D Occurrence Handle10.1007/s00535-004-1464-0
A Andoh T Tsujikawa O Inatomi Y Deguchi M Sasaki H Obata et al. (2005) ArticleTitleLeukocytapheresis therapy modulates circulating T cell subsets in patients with ulcerative colitis Ther Apher Dial 9 270–6 Occurrence Handle15967005 Occurrence Handle1:CAS:528:DC%2BD2MXps1Kht7o%3D Occurrence Handle10.1111/j.1774-9987.2005.00270.x
D Rachmilewitz (1989) ArticleTitleCoated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial BMJ 298 82–6 Occurrence Handle2563951 Occurrence Handle1:STN:280:DyaL1M7ltVOitg%3D%3D Occurrence Handle10.1136/bmj.298.6666.82
K Osumi Y Ozeki S Saito Y Nagamura H Ito Y Kimura et al. (2001) ArticleTitleDevelopment and assessment of enzyme immunoassay for platelet-derived microparticles Thromb Haemost 85 326–30 Occurrence Handle11246556 Occurrence Handle1:CAS:528:DC%2BD3MXhvVKrsL0%3D
Y Kohgo T Ashida A Maemoto T Ayabe (2003) ArticleTitleLeukocytapheresis for treatment of IBD J Gastroenterol 38 Suppl 15 51–4 Occurrence Handle12698872
M Noguchi N Hiwatashi T Hayakawa T Toyota (1998) ArticleTitleLeukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: role of bystander suppression Ther Apher 2 109–14 Occurrence Handle10225710 Occurrence Handle1:CAS:528:DyaK1cXjslGgurk%3D
K Mitsuyama A Suzuki S Matsumoto N Tomiyasu K Takaki H Takedatsu et al. (2005) ArticleTitleDiminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis Clin Exp Immunol 141 130–40 Occurrence Handle15958079 Occurrence Handle1:CAS:528:DC%2BD2MXms1ehs74%3D Occurrence Handle10.1111/j.1365-2249.2005.02825.x
G Adamus (1985) Platelet aggregation GL Longenecker (Eds) The platelets: physiology and pharmacology Academic New York 1–11
MJ Webberley MT Hart V Melikian (1993) ArticleTitleThromboembolism in inflammatory bowel disease: role of platelets Gut 34 247–51 Occurrence Handle8432482 Occurrence Handle1:STN:280:DyaK3s7mt1Gnsg%3D%3D
CH Gemmell MV Sefton EL Yeo (1993) ArticleTitlePlatelet-derived microparticle formation involves glycoprotein IIb–IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect J Biol Chem 268 14586–9 Occurrence Handle8325838 Occurrence Handle1:CAS:528:DyaK3sXlsFKqsr4%3D
S Nomura (2001) ArticleTitleFunction and clinical significance of platelet-derived microparticles Int J Hematol 74 397–404 Occurrence Handle11794694 Occurrence Handle1:STN:280:DC%2BD38%2FmslCgtA%3D%3D Occurrence Handle10.1007/BF02982082
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yagi, Y., Andoh, A., Inatomi, O. et al. Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis. J Gastroenterol 41, 540–546 (2006). https://doi.org/10.1007/s00535-006-1797-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00535-006-1797-y